Evaluation of the Added Value of Ciprofol for Anesthesia and Sedation Based on Health Technology Assessment
10.3870/j.issn.1004-0781.2025.01.013
- VernacularTitle:基于卫生技术评估的环泊酚用于麻醉镇静的附加价值评价
- Author:
Chun YANG
1
;
Zhengmin MA
;
Fuhai JI
;
Jixiang ZHU
Author Information
1. 苏州大学附属第一医院麻醉科,苏州 215000
- Publication Type:Journal Article
- Keywords:
Ciprofol;
Propofol;
Health technology assessment;
Anesthesia sedation;
Drug added value
- From:
Herald of Medicine
2025;44(1):103-108
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the added value of ciprofol and to provide the reference for clinical selection of ciprofol and propofol in patient individualized anesthesia and sedation program.Methods The relative safety,relative effectiveness,innovation/suitability,and economy of propofol and ciprofol were compared and scored according to the Guidelines for Drug Added Value Evaluation based on Health Technology Evaluation.Results Compared with the value of propofol,the total value of ciprofol was 57 points,which was reflected as a small increase.The sedation effect of the two drugs was similar,but propofol had more economic cost advantages,and ciprofol was better than propofol in injection pain,hypotension,and other adverse reactions.Conclusion Propofol and ciprofol should be used reasonably in anesthesia and sedation,considering the health status and economic condition of patients.
